Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,002 public trials 569 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Active, Not Recruiting

Belantamab Mafodotin in Newly Diagnosed Transplant Eligible Multiple Myeloma Patients

NCT04802356

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
  • Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain
  • Hospital Universitario de Salamanca Salamanca, Castille and León, Spain
  • Complejo Universitario Hospitalario de Santiago Santiago de Compostela, Galicia, Spain
View Trial Details
Active, Not Recruiting

A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

NCT06045806

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Local Institution - 0131 Los Angeles, California, United States
  • Local Institution - 0126 Orange, California, United States
  • Local Institution - 0113 Sacramento, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 101 locations
View Trial Details
Active, Not Recruiting

Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101

NCT03741127

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of California Davis Davis, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

NCT04270175

Conditions
AL Amyloidosis, Alzheimer Disease, Amyloid, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Boston University Medical Center Boston, Massachusetts, United States
  • Weill Cornell Medicine - Multiple Myeloma Center New York, United States
  • Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details

Related conditions